Authors:
Ropponen, KM
Kellokoski, JK
Pirinen, RT
Moisio, KI
Eskelinen, MJ
Alhava, EM
Kosma, VM
Citation: Km. Ropponen et al., Expression of transcription factor AP-2 in colorectal adenomas and adenocarcinomas; comparison of immunohistochemistry and in situ hybridisation, J CLIN PATH, 54(7), 2001, pp. 533-538
Authors:
Ropponen, KM
Kellokoski, JK
Lipponen, PK
Eskelinen, MJ
Alanne, L
Alhava, EM
Kosma, VM
Citation: Km. Ropponen et al., Expression of inducible nitric oxide synthase in colorectal cancer and itsassociation with prognosis, SC J GASTR, 35(11), 2000, pp. 1204-1211
Authors:
Bohm, JP
Niskanen, LK
Pirinen, RT
Kiraly, K
Kellokoski, JK
Moisio, KI
Eskelinen, MJ
Tulla, HE
Hollmen, S
Alhava, EM
Kosma, VM
Citation: Jp. Bohm et al., Reduced CD44 standard expression is associated with tumour recurrence and unfavourable outcome in differentiated thyroid carcinoma, J PATHOLOGY, 192(3), 2000, pp. 321-327
Authors:
Karjalainen, JM
Kellokoski, JK
Mannermaa, AJ
Kujala, HE
Moisio, KI
Mitchell, PJ
Eskelinen, MJ
Alhava, EM
Kosma, VM
Citation: Jm. Karjalainen et al., Failure in post-transcriptional processing is a possible inactivation mechanism of AP-2 alpha in cutaneous melanoma, BR J CANC, 82(12), 2000, pp. 2015-2021
Authors:
Karjalainen, JM
Tammi, RH
Tammi, MI
Eskelinen, MJ
Agren, UM
Parkkinen, JJ
Alhava, EM
Kosma, VM
Citation: Jm. Karjalainen et al., Reduced level of CD44 and hyaluronan associated with unfavorable prognosisin clinical stage I cutaneous melanoma, AM J PATH, 157(3), 2000, pp. 957-965
Citation: Mj. Eskelinen et Uh. Haglund, Prognosis of human pancreatic adenocarcinoma: Review of clinical and histopathological variables and possible uses of new molecular methods, EURO J SURG, 165(4), 1999, pp. 292-306
Authors:
Ropponen, KM
Eskelinen, MJ
Lipponen, PK
Alhava, EM
Kosma, VM
Citation: Km. Ropponen et al., Reduced expression of alpha catenin is associated with poor prognosis in colorectal carcinoma, J CLIN PATH, 52(1), 1999, pp. 10-16
Authors:
Ropponen, KM
Kellokoski, JK
Lipponen, PK
Pietilainen, T
Eskelinen, MJ
Alhava, EM
Kosma, VM
Citation: Km. Ropponen et al., P21/WAF1 expression in human colorectal carcinoma: association with p53, transcription factor AP-2 and prognosis, BR J CANC, 81(1), 1999, pp. 133-140
Authors:
Setala, LP
Tammi, MI
Tammi, RH
Eskelinen, MJ
Lipponen, PK
Agren, UM
Parkkinen, J
Alhava, EM
Kosma, VM
Citation: Lp. Setala et al., Hyaluronan expression in gastric cancer cells is associated with local andnodal spread and reduced survival rate, BR J CANC, 79(7-8), 1999, pp. 1133-1138
Authors:
Karjalainen, JM
Eskelinen, MJ
Kellokoski, JK
Reinikainen, M
Alhava, EM
Kosma, VM
Citation: Jm. Karjalainen et al., p21(WAF1/CIP1) expression in stage I cutaneous malignant melanoma: its relationship with p53, cell proliferation and survival, BR J CANC, 79(5-6), 1999, pp. 895-902
Authors:
Karjalainen, JM
Eskelinen, MJ
Nordling, S
Lipponen, PK
Alhava, EM
Kosma, VM
Citation: Jm. Karjalainen et al., Mitotic rate and S-phase fraction as prognostic factors in stage I cutaneous malignant melanoma, BR J CANC, 77(11), 1998, pp. 1917-1925